ANIP today
$71.42+$0.36 (+0.51%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourSymmetric Triangle
15 minSymmetric Triangle
5 minAscending Triangle
Daily trend turns down below $56.71
Key levels
Resistance$76.00
Resistance$73.27
Support$70.66
Support$67.14
Latest news & SEC filings
AnalystGuggenheim keeps Buy rating on ANI Pharmaceuticals, lifts price target
AnalystGuggenheim keeps Buy rating on ANI Pharmaceuticals, lifts target to $121
All ANIP news →About ANI Pharmaceuticals
ANI Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and sells prescription medicines. It operates through three segments: Rare Disease, Generics, and Brands. Its products include Cortrophin Gel, ILUVIEN, and YUTIQ, along with a portfolio of generic drugs and branded treatments. The company sells to patients, physicians, and healthcare providers, primarily in the United States, with additional operations in Europe, Asia, and the Middle East.
Based on the company's 10-K filed Feb 27, 2026.
Nasdaq · Healthcare
ANI PHARMACEUTICALS INC (ANIP)
What Is the Price Target for ANIP?
SEPT Low Target
$85.00
SEPT Mid Target
$90.00
SEPT High Target
$124.00
Analyst Consensus
$90.00
Is ANIP a Buy or Sell Right Now?
Thesis
- •Revenue growing 43.8% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ANIP.
Start Free Trial →Is ANIP Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$99.54
39
Moat Score
NONE
6/9
Piotroski Score
2.3
Altman Z-Score
What Is Smart Money Doing with ANIP?
Insider Signal
SELLING
0 buys / 13 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| CAREY STEPHEN P. | officer | Sale | 2,850 | $208K | Oct 29, 2026 |
| Lalwani Nikhil | director officer | Sale | 5,400 | $388K | Oct 15, 2026 |
| CAREY STEPHEN P. | officer | Sale | 2,850 | $208K | Sep 29, 2026 |
| CAREY STEPHEN P. | officer | Sale | 2,850 | $207K | Aug 31, 2026 |
| Gosebruch Henry O | director | Buy | 6,662 | - | Aug 19, 2026 |
| Cook Meredith | officer | Sale | 500 | $41K | Jun 12, 2026 |
| HAUGHEY THOMAS | director | Sale | 2,000 | $162K | Jun 8, 2026 |
| CAREY STEPHEN P. | officer | Buy | 3,312 | $164K | Jun 5, 2026 |
| CAREY STEPHEN P. | officer | Sale | 3,312 | $265K | Jun 5, 2026 |
| Thoma Jeanne | director | Buy | 4,357 | - | May 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ANIP Growth Story
Revenue YoY
43.8%
3yr Revenue CAGR
40.8%
EPS Growth YoY
419.23%
FCF Growth YoY
258.7%
Revenue Trend
STRONG
Dark Pool Trades for ANIP
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ANIP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:35:07 | $71.36 | 1,060 | $$76K | SELL |
| 16:37:31 | $71.13 | 2,500 | $$178K | MIDPOINT |
| 16:14:30 | $71.35 | 1,000 | $$71K | BUY |
| 16:10:44 | $71.23 | 1,000 | $$71K | MIDPOINT |
| 22:24:27 | $71.06 | 1,400 | $$99K | BUY |
5 dark pool trades shown · $$496K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ANI PHARMACEUTICALS INC (ANIP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ANIP — frequently asked questions
What is ANIP stock price today?
ANI PHARMACEUTICALS INC (ANIP) is at $71.42, up 0.51% (+$0.36) at the Nov 13, 2026 close.
Why is ANIP stock moving today?
Latest ANIP news — Nov 7, 2026: Guggenheim keeps Buy rating on ANI Pharmaceuticals, lifts price target · Nov 6, 2026: Guggenheim keeps Buy rating on ANI Pharmaceuticals, lifts target to $121
What is the ANIP price target?
The average analyst price target for ANIP is $90.00, ranging from $85 to $124, based on 3 analysts. Latest: Oppenheimer initiates on Sep 23, 2026.
What do analysts rate ANIP?
Analyst ratings for ANIP: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did ANIP beat earnings?
ANIP last reported on Aug 7, 2026: EPS $2.21 vs $2.04 expected — a beat of 8.3%.
What is ANIP's P/E ratio?
ANIP trades at a P/E of 15.6 vs a Healthcare average of 18.5.
Does ANIP pay a dividend?
Yes. ANIP's dividend yield is 0.07%.
What are ANIP support and resistance levels?
Support: $70.66, $67.14, $62.60. Resistance: $73.27, $76.00, $79.43.
What are insiders doing with ANIP?
Insider activity: SELLING, 0 buys and 13 sells in the last 90 days.
What is the latest news on ANIP?
Nov 7, 2026: Guggenheim keeps Buy rating on ANI Pharmaceuticals, lifts price target · Nov 6, 2026: Guggenheim keeps Buy rating on ANI Pharmaceuticals, lifts target to $121